Cargando…
Resolvin D2 Reduces Chronic Neuropathic Pain and Bone Cancer Pain via Spinal Inhibition of IL-17 Secretion, CXCL1 Release and Astrocyte Activation in Mice
Chronic pain burdens patients and healthcare systems worldwide. Pain control remains urgently required. IL-17 (interleukin-17)-mediated neuroinflammation is of unique importance in spinal nociceptive transduction in pathological pain development. Recently, resolvin D2 (RvD2), as a bioactive, special...
Autores principales: | Pang, Jun, Xin, Pengfei, Kong, Ying, Wang, Zhe, Wang, Xiaopeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856778/ https://www.ncbi.nlm.nih.gov/pubmed/36672133 http://dx.doi.org/10.3390/brainsci13010152 |
Ejemplares similares
-
Role of Resolvins in Inflammatory and Neuropathic Pain
por: Park, Jaeik, et al.
Publicado: (2023) -
Crosstalk between Spinal Astrocytes and Neurons in Nerve Injury-Induced Neuropathic Pain
por: Wang, Wei, et al.
Publicado: (2009) -
IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines
por: Sun, Caixia, et al.
Publicado: (2017) -
Association of the resolvin precursor 17-HDHA, but not D- or E- series resolvins, with heat pain sensitivity and osteoarthritis pain in humans
por: Valdes, Ana M., et al.
Publicado: (2017) -
Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury
por: Wu, Xiao-Bo, et al.
Publicado: (2018)